logo
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe
Generic substitution
Comment on: Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe by Johnston et al. [1],
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Medical management of paraquat ingestion
Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal
Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man
The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase
Drug−disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity
Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective
Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes
Sensitive studies with a significant dose–response curve for inhaled corticosteroids to investigate equivalent relative potency are feasible
Guidelines to establish relative potency are not in touch with reality
Effect of nicotine on cytochrome P450 1A2 activity
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus
Stem cells in the respiratory system
THERAPEUTIC DRUG MONITORING IS MANDATORY IN CRITICALLY ILL PATIENTS TREATED WITH VORICONAZOLE
MODELING OF THE AGE-RELATED PHARMACOKINETICS IN CHILDREN. A DATA-DRIVEN ANALYSIS OF BUSULFAN PRIOR TO HAEMOPOIETIC STEM CELL TRANSPLANTATION
CD3+CD4+−LYMPHOCYTES AS BIOMARKER PREDICTING THE OUTCOME OF PEDIATRIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
QUALITY OF INFORMATION ABOUT OLDER PATIENTS IN PARs AND SPCs: EVALUATION OF THREE RECENTLY APPROVED DRUGS
ADVERSE DRUG REACTIONS OF ANTIDEPRESSANTS IN A NATURALISTIC SETTING
STATINS DO NOT PREVENT ISCHEMIA-INDUCED DETERIORATION IN FLOW-MEDIATED DILATION
PREDICTING GLOMERULAR FILTRATION RATE USING CLEARANCE OF AMIKACIN IN NEONATES - MODEL EVALUATION
POSACONAZOLE THERAPEUTIC DRUG MONITORING IN DAILY PRACTICE
A GLUCAGON CHALLENGE TEST IN TYPE 2 DIABETES MELLITUS PATIENTS
ACUTE INTOXICATIONS: HIGHLY VARIABLE ADMISSION POLICY IN 6 DUTCH HOSPITALS
THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON INTRAOPERATIVE BLOOD PRESSURE
PET-CT SCANS WITH RADIOLABELED DOCETAXEL TO MEASURE DOCETAXEL UPTAKE IN LUNG CANCER
EDUCATION IN GERIATRIC PHARMACOLOGY FOR MEDICAL AND PHARMACY STUDENTS, PHYSICIANS AND PHARMACISTS: A SYSTEMATIC REVIEW
CLOMIPRAMINE IN NEONATES: ELIMINATION KINETICS AND WITHDRAWAL SYMPTOMS AFTER IN UTERO EXPOSURE
LACK OF EXCRETION OF THE ACTIVE MOIETY OF BISACODYL AND SODIUM PICOSULFATE INTO THE HUMAN BREAST MILK: A MULTIPLE DOSE STUDY IN HEALTHY LACTATING WOMEN
A TWO PERIOD STUDY IN HEALTHY VOLUNTEERS TO DETERMINE THE REPEATABILITY OF A QUANTITATIVE SENSORY TESTING BATTERY AND THE INTRADERMAL CAPSAICIN MODEL
CRITICALL ILLNESS IS A MAJOR DETERMINANT FOR MIDAZOLAM AND METABOLITE CLEARANCE IN CHILDREN
DIPYRIDAMOLE REDUCES ISCHEMIA-REPERFUSION INJURY IN AN EX-VIVO HUMAN ATRIAL MODEL
THE EFFECT OF OLANZAPINE ON TETRAHYDROCANNABINOL-INDUCED PSYCHOMIMETIC SYMPTOMS
TETRAHYDROCANABINOL TABLET NAMISOL®: FIRST IN HUMAN PK, PD AND TOLERABILITY
PARACETAMOL PHARMACOKINETICS IN TERM AND PRETERM NEONATES
THE BLISTER COLLECTION METHOD: A NEW WAY OF MEASURING MEDICATION ADMINISTRATION ERROR
NO INDICATIONS FOR CAUSAL RELATIONSHIP BETWEEN CHRONIC OR ACUTE HYPERGLYCEMIA AND SYSTEMIC INFLAMMATION IN TYPE 2 DIABETES MELLITUS
STUDY ON THE EFFECT OF THE SHORT-TERM COMBINED USE OF NON STEROIDAL ANTIINFLAMMATORY DRUGS WITH DIURETICS AND/OR RAAS-INHIBITORS ON RENAL-FUNCTION AND BLOODPRESSURE
IMPACT OF REGULATORY RISK COMMUNICATION IN THE NETHERLANDS; 48 TIME SERIES ANALYSES
LONG-TERM EFFECTS OF MELATONIN ON SLEEP AND QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS (MELODY STUDY)
CLINICAL RULE GUIDED THERAPEUTIC DRUG MONITORING OF DIGOXIN: DEVELOPMENT, VALIDATION AND POTENTIAL VALUE
CAFFEINE EFFECTS ON CENTRAL AND AUTONOMOUS NERVOUS SYSTEM PARAMETERS IN ADOLESCENTS
INTRA-ARTERIAL VEGF ANTIBODIES DO NOT ACUTELY AFFECT VASCULAR TONE IN HEALTHY VOLUNTEERS
IS IT NECESSARY TO STRUCTURE THE THERAPEUTIC PART OF THE MEDICAL RECORD?
DETERMINATION OF MOXIFLOXACIN IN BLOOD USING DRIED BLOOD SPOTS ANALYSIS
SCALING CLEARANCE OF PROPOFOL FROM PRETERM NEONATES TO ADULTS
POTENTIAL VALUE OF A CLINICAL RULE ON THERAPEUTIC DRUG MONITORING REQUESTS OF LITHIUM
A CLINICAL STUDY IN HEALTHY VOLUNTEERS TO EVALUATE DRIED BLOOD SPOT SAMPLING FOR SAFETY, PHARMACOKINETIC AND PHARMACOGENETIC STUDIES
ATORVASTATINE DOES NOT REDUCE PHOSPHATIDYLSERINE EXPOSITION AFTER FOREARM ISCHEMIA AND REPERFUSION IN HUMANS IN-VIVO